Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia

Go back to Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
PACIRA (NASDAQ: PCRX) Delayed: 24.69 +0.21 (0.86%)
Previous Close $24.48    52 Week High $80.25 
Open $24.36    52 Week Low $30.25 
Day High $24.72    P/E N/A 
Day Low $24.20    EPS $-2.08 
Volume 680,877